Mrs. Karol Mmabaji, Rwanda, successful treatment of Gullian Bare Syndrome (GBS) in Medanta-themedicity Hospital, Gurugram,India.
Ms. Karol (29 yrs.),
accompanied by sister Tina, from Rwanda, received medical management during January 2019.
Ms. Karol was suffered from a rare type of neurological disorder (GBS-Guillain-Barre syndrome), which led her almost paralysed from all her daily activities. In a very short time her health deteriorated, was able to do her daily activities which led to an urgent medical attention to save her life. Local doctors could not diagnose her real cause of illness.
In Rwanda she had
been advised for Medanta through local doctors.
We received her
medical summery and shared got tentative treatment plan with patient.
She was completely wheel chair bound due to inability to walk when she arrived at Delhi airport; she picked-up well by Humane Team (Mr. Ali), and then was immediately transferred to hospital.
On arrival in
India she got special attention Rwanda High commission New Delhi and treated
under special consideration and Humana’s Team assisted her during hospital stay
and stay in India for accommodation.
We consulted Dr.
Verma, neurology department, after detailed assessment and Investigations, she
had been diagnosed with a very rare disease GBS, then accordingly most appropriate
medical management (I.V. Immunoglobulins, IVIG) was give and physiotherapy
started. After completion of IVIG, She was given Ayurveda therapy (Ancient
Indian system of therapy) and Ayurveda massaged. At time of discharge, Humane
Team had arranged accommodation as per her choice in her budget near-by the hospital.
During follow-up she received physiotherapy hotel as advised and Ayurveda
treatment was continue on regular basis in hospital. After almost 2 weeks of
treatment she found miracle in her life was started to walk and was able to do
daily life activities without any assistance.
After, almost 15
days of total stay in India, she went back to Rwanda. Now, she is back to her
routine job
We wish him a
great life ahead.